Effect of Orofacial Myofunctional Therapy with Auto-Monitoring on the Apnea–Hypopnea Index and Secondary Outcomes in Treatment-Naïve Patients with Mild to Moderate Obstructive Sleep Apnea (OMTaOSA): A Multicenter Randomized Controlled Trial Protocol
International Journal of Orofacial Myology and Myofunctional Therapy · 09.09.2025 · 51 (2) · 8
DOI: 10.3390/ijom51020008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Orofacial Myology and Myofunctional Therapy, online erschienen am 09.09.2025. Verfasst von Harald Hrubos-Strøm und 11 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020.
Abstract (Originalsprache)
Background
The aim of this article is to describe the protocol of a large, multicenter randomized controlled trial evaluating the effects of orofacial myofunctional therapy with auto-monitoring (OMTa) versus auto-monitoring alone on obstructive sleep apnea (OSA) assessed by the apnea–hypopnea index and other pre-specified outcomes.
Method
The OMTaOSA study protocol was registered at ClinicalTrials.gov (NCT06079073) in August 2023, and data collection ended in January 2025. One hundred and four participants with mild and moderate OSA were included. Randomization was conducted in a 1:1 ratio, using sex-stratified blocks. The intervention was a standardized protocol of OMT exercises previously shown to be effective, auto-monitoring with a Withings scan watch, and feedback from self-reports. Controls received watches and access to the same application without the exercise module. Sleep was measured over three nights at baseline and after three months. The sleep scorer and researchers evaluating other outcomes were blinded to the treatment allocation. Change in the apnea–hypopnea index was defined as the primary outcome. Secondary outcomes are published on Clinicaltrials.gov.
Results
The results of the trial are still in preparation.
Conclusions
By addressing the limitations of previous OMT studies, this trial may clarify the effectiveness of digitally delivered OMT for patients with mild to moderate OSA.
Förderung
- Horizon 2020
Zitieren
APA
Hrubos-Strøm, H., Hansen, D. D., Feng, X., Mäkinen, H., Tinbod, U., Köster, A., Vaher, H., Klungsøyr, O., Saavedra, J. M., Skirbekk, H., Dammen, T., & Jagomägi, T. (2025). Effect of Orofacial Myofunctional Therapy with Auto-Monitoring on the Apnea–Hypopnea Index and Secondary Outcomes in Treatment-Naïve Patients with Mild to Moderate Obstructive Sleep Apnea (OMTaOSA): A Multicenter Randomized Controlled Trial Protocol. International Journal of Orofacial Myology and Myofunctional Therapy, 51(2), 8. https://doi.org/10.3390/ijom51020008
Vancouver
Hrubos-Strøm H, Hansen DD, Feng X, Mäkinen H, Tinbod U, Köster A, et al. Effect of Orofacial Myofunctional Therapy with Auto-Monitoring on the Apnea–Hypopnea Index and Secondary Outcomes in Treatment-Naïve Patients with Mild to Moderate Obstructive Sleep Apnea (OMTaOSA): A Multicenter Randomized Controlled Trial Protocol. International Journal of Orofacial Myology and Myofunctional Therapy. 2025;51(2):8. doi:10.3390/ijom51020008
BibTeX
@article{HrubosStrm2025,
author = {Hrubos-Strøm, Harald and Hansen, Diana Dobran and Feng, Xin and Mäkinen, Hanna and Tinbod, Unn and Köster, Andres and Vaher, Heisl and Klungsøyr, Ole and Saavedra, Jose M. and Skirbekk, Helge and Dammen, Toril and Jagomägi, Triin},
title = {Effect of Orofacial Myofunctional Therapy with Auto-Monitoring on the Apnea–Hypopnea Index and Secondary Outcomes in Treatment-Naïve Patients with Mild to Moderate Obstructive Sleep Apnea (OMTaOSA): A Multicenter Randomized Controlled Trial Protocol},
journal = {International Journal of Orofacial Myology and Myofunctional Therapy},
year = {2025},
volume = {51},
number = {2},
pages = {8},
doi = {10.3390/ijom51020008}
}
EUVIMED